Page last updated: 2024-08-21

perflubron and 2019 Novel Coronavirus Disease

perflubron has been researched along with 2019 Novel Coronavirus Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bartoloni, A; Berni, A; Corona, G; Fanelli, A; Fibbi, B; Lavorini, F; Maggi, M; Malandrino, D; Nozzoli, C; Parenti, G; Peri, A; Peris, A; Pieralli, F; Pini, R; Poggesi, L; Scocchera, G; Ungar, A	1

Other Studies

1 other study(ies) available for perflubron and 2019 Novel Coronavirus Disease

Article	Year
Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome. European journal of endocrinology, 2021, May-28, Volume: 185, Issue:1 Topics: Aged; Aged, 80 and over; Comorbidity; COVID-19; Critical Care; Female; Fluorocarbons; Hospital Mortality; Hospitalization; Humans; Hydrocarbons, Brominated; Hypernatremia; Hyponatremia; Interleukin-6; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Severity of Illness Index; Sodium	2021

Article

Year

Serum sodium alterations in SARS CoV-2 (COVID-19) infection: impact on patient outcome.

European journal of endocrinology, 2021, May-28, Volume: 185, Issue:1

Topics: Aged; Aged, 80 and over; Comorbidity; COVID-19; Critical Care; Female; Fluorocarbons; Hospital Mortality; Hospitalization; Humans; Hydrocarbons, Brominated; Hypernatremia; Hyponatremia; Interleukin-6; Male; Middle Aged; Respiration, Artificial; Retrospective Studies; SARS-CoV-2; Severe acute respiratory syndrome-related coronavirus; Severity of Illness Index; Sodium

2021